{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:02:27Z","timestamp":1791000147174,"version":"4.1.0"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["962110"],"award-info":[{"award-number":["962110"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.biopha.2021.112346","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T20:42:49Z","timestamp":1634330569000},"page":"112346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Role of myeloid-derived suppressor cells in viral respiratory infections; Hints for discovering therapeutic targets for COVID-19"],"prefix":"10.1016","volume":"144","author":[{"given":"Khadijeh","family":"Koushki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Salemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad","family":"Miri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaser","family":"Arjeini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Keshavarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Ghaemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.biopha.2021.112346_bib1","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1016\/S1473-3099(17)30238-4","article-title":"Global epidemiology of non-influenza RNA respiratory viruses: data gaps and a growing need for surveillance","volume":"17","author":"Tang","year":"2017","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2021.112346_bib2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1128\/CMR.00032-09","article-title":"Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology","volume":"23","author":"Tregoning","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2021.112346_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11658-020-00211-2","article-title":"Metabolic host response and therapeutic approaches to influenza infection","volume":"25","author":"Keshavarz","year":"2020","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.biopha.2021.112346_bib4","series-title":"Physiology in Perspective: A Key Role of Physiology in understanding COVID-19","author":"Sieck","year":"2020"},{"issue":"11","key":"10.1016\/j.biopha.2021.112346_bib5","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1080\/17476348.2020.1807945","article-title":"Innate and adaptive immune responses in respiratory virus infection: implications for the clinic","volume":"14","author":"Stambas","year":"2020","journal-title":"Expert Rev. Respir. Med."},{"key":"10.1016\/j.biopha.2021.112346_bib6","series-title":"Seminars in immunopathology","first-page":"471","article-title":"The host immune response in respiratory virus infection: balancing virus clearance and immunopathology","author":"Newton","year":"2016"},{"key":"10.1016\/j.biopha.2021.112346_bib7","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.3389\/fimmu.2020.01979","article-title":"Innate immune responses to highly pathogenic coronaviruses and other significant respiratory viral infections","volume":"11","author":"Ahmed-Hassan","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112346_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-016-0474-9","article-title":"Respiratory viral infections and host responses; insights from genomics","volume":"17","author":"Troy","year":"2016","journal-title":"Respir. Res."},{"key":"10.1016\/j.biopha.2021.112346_bib9","first-page":"1","article-title":"Neutrophils in respiratory viral infections","author":"Johansson","year":"2021","journal-title":"Mucosal Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2021.112346_bib10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrc3581","article-title":"History of myeloid-derived suppressor cells","volume":"13","author":"Talmadge","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2021.112346_bib11","first-page":"1","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","author":"Veglia","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112346_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/0008-5472.CAN-06-3037","article-title":"The terminology issue for myeloid-derived suppressor cells","volume":"67","author":"Gabrilovich","year":"2007","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.biopha.2021.112346_bib13","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00262-010-0855-8","article-title":"Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity","volume":"59","author":"Ostrand-Rosenberg","year":"2010","journal-title":"Cancer Immunol., Immunother."},{"issue":"2","key":"10.1016\/j.biopha.2021.112346_bib14","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s13277-015-4477-9","article-title":"The immunobiology of myeloid-derived suppressor cells in cancer","volume":"37","author":"Motallebnezhad","year":"2016","journal-title":"Tumor Biol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112346_bib15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112346_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00262-005-0048-z","article-title":"Role of immature myeloid cells in mechanisms of immune evasion in cancer","volume":"55","author":"Kusmartsev","year":"2006","journal-title":"Cancer Immunol., Immunother."},{"issue":"2","key":"10.1016\/j.biopha.2021.112346_bib17","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/0008-5472.CAN-05-1299","article-title":"Gr-1+ CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host","volume":"66","author":"Huang","year":"2006","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.biopha.2021.112346_bib18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/08830185.2016.1206097","article-title":"Tumor-associated macrophages and myeloid-derived suppressor cells as immunosuppressive mechanism in ovarian cancer patients: progress and challenges","volume":"35","author":"Ok\u0142a","year":"2016","journal-title":"Int. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112346_bib19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112346_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol. Res."},{"issue":"2","key":"10.1016\/j.biopha.2021.112346_bib21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112346_bib22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1182\/blood.V95.1.212","article-title":"Nitric oxide-producing CD11b(+)Ly-6G(Gr-1)(+)CD31(ER-MP12)(+) cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice","volume":"95","author":"Angulo","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2021.112346_bib23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.coi.2018.03.007","article-title":"Myeloid derived-suppressor cells: their role in cancer and obesity","volume":"51","author":"Ostrand-Rosenberg","year":"2018","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112346_bib24","doi-asserted-by":"crossref","first-page":"757","DOI":"10.4049\/jimmunol.1600759","article-title":"Kinetics of myeloid-derived suppressor cell frequency and function during simian immunodeficiency virus infection, combination antiretroviral therapy, and treatment interruption","volume":"198","author":"Dross","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2021.112346_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.virol.2016.08.031","article-title":"Myeloid-derived suppressor cells in murine AIDS inhibit B-cell responses in part via soluble mediators including reactive oxygen and nitrogen species, and TGF-\u03b2","volume":"499","author":"Rastad","year":"2016","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.biopha.2021.112346_bib26","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.3390\/cells9122715","article-title":"HCV-associated exosomes upregulate RUNXOR and RUNX1 expressions to promote MDSC expansion and suppressive functions through STAT3\u2013miR124 axis","volume":"9","author":"Thakuri","year":"2020","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.biopha.2021.112346_bib27","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1172\/JCI36264","article-title":"Invariant NKT cells reduce the immunosuppressive activity of influenza A virus\u2013induced myeloid-derived suppressor cells in mice and humans","volume":"118","author":"De Santo","year":"2008","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.biopha.2021.112346_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025242","article-title":"Increased MDSC accumulation and Th2 biased response to influenza A virus infection in the absence of TLR7 in mice","volume":"6","author":"Jeisy-Scott","year":"2011","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.biopha.2021.112346_bib29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10875-020-00920-5","article-title":"SARS-CoV-2-induced ARDS associates with MDSC expansion, lymphocyte dysfunction, and arginine shortage","volume":"41","author":"Reizine","year":"2021","journal-title":"J. Clin. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2021.112346_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-03125-1","article-title":"Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome","volume":"11","author":"Sacchi","year":"2020","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.biopha.2021.112346_bib31","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.18632\/aging.202571","article-title":"Elevated frequencies of CD14+ HLA-DRlo\/neg MDSCs in COVID-19 patients","volume":"13","author":"Xue","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.biopha.2021.112346_bib32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fimmu.2021.614599","article-title":"Reduced expression of autophagy markers and expansion of myeloid-derived suppressor cells correlate with poor T cell response in severe COVID-19 patients","volume":"12","author":"Tomi\u0107","year":"2021","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2021.112346_bib33","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1038\/s41418-020-0572-6","article-title":"Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)","volume":"27","author":"Agrati","year":"2020","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.biopha.2021.112346_bib34","doi-asserted-by":"crossref","first-page":"942","DOI":"10.4049\/jimmunol.123.2.942","article-title":"Induction of allograft tolerance after total lymphoid irradiation (TLI): development of suppressor cells of the mixed leukocyte reaction (MLR)","volume":"123","author":"Slavin","year":"1979","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2021.112346_bib35","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1002\/eji.201040895","article-title":"The biology of myeloid\u2010derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity","volume":"40","author":"Youn","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2021.112346_bib36","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/infdis\/jix494","article-title":"Identification of a novel subset of myeloid-derived suppressor cells during chronic staphylococcal infection that resembles immature eosinophils","volume":"216","author":"Goldmann","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2021.112346_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2021.112346_bib38","doi-asserted-by":"crossref","first-page":"937","DOI":"10.4049\/jimmunol.0804253","article-title":"Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells","volume":"183","author":"Hanson","year":"2009","journal-title":"J. Immunol. (Baltim., Md.: 1950)"},{"issue":"1","key":"10.1016\/j.biopha.2021.112346_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/0008-5472.CAN-09-2587","article-title":"Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine","volume":"70","author":"Srivastava","year":"2010","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.biopha.2021.112346_bib40","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2174\/1381612043452893","article-title":"Inhibition of MHC II gene transcription by nitric oxide and antioxidants","volume":"10","author":"Harari","year":"2004","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.biopha.2021.112346_bib41","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4049\/jimmunol.168.2.689","article-title":"Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism","volume":"168","author":"Mazzoni","year":"2002","journal-title":"J. Immunol. (Baltim., Md.: 1950)"},{"issue":"7","key":"10.1016\/j.biopha.2021.112346_bib42","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nm1609","article-title":"Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer","volume":"13","author":"Nagaraj","year":"2007","journal-title":"Nat. Med."},{"issue":"13","key":"10.1016\/j.biopha.2021.112346_bib43","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1158\/0008-5472.CAN-07-6621","article-title":"Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells","volume":"68","author":"Serafini","year":"2008","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2021.112346_bib44","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4049\/jimmunol.179.2.977","article-title":"Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response","volume":"179","author":"Sinha","year":"2007","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2021.112346_bib45","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/ni.1791","article-title":"Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis","volume":"10","author":"Murai","year":"2009","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112346_bib46","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4049\/jimmunol.182.1.240","article-title":"Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-\u03b21","volume":"182","author":"Li","year":"2009","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2021.112346_bib47","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1002\/eji.201041037","article-title":"IL\u20101\u03b2 regulates a novel myeloid\u2010derived suppressor cell subset that impairs NK cell development and function","volume":"40","author":"Elkabets","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2021.112346_bib48","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/eji.200939486","article-title":"Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development","volume":"39","author":"Greifenberg","year":"2009","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112346_bib49","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/00365521.2010.516450","article-title":"Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function","volume":"46","author":"Hu","year":"2011","journal-title":"Scand. J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.biopha.2021.112346_bib50","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1182\/blood-2007-07-099226","article-title":"Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell\u2013suppressive activity","volume":"111","author":"Movahedi","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.biopha.2021.112346_bib51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/imm.13143","article-title":"Tissue-resident innate immunity in the lung","volume":"159","author":"Ardain","year":"2020","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.biopha.2021.112346_bib52","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/sji.12140","article-title":"Passive transfer of tumour\u2010derived MDSCs inhibits asthma\u2010related airway inflammation","volume":"79","author":"Song","year":"2014","journal-title":"Scand. J. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2021.112346_bib53","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/mi.2010.41","article-title":"TLR4\/MyD88-induced CD11b+Gr-1intF4\/80+ non-migratory myeloid cells suppress Th2 effector function in the lung","volume":"3","author":"Arora","year":"2010","journal-title":"Mucosal Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112346_bib54","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1004983","article-title":"Phenotype, development, and biological function of myeloid-derived suppressor cells","volume":"5","author":"Zhao","year":"2016","journal-title":"Oncoimmunology"},{"issue":"9","key":"10.1016\/j.biopha.2021.112346_bib55","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101013","article-title":"S100A8 may govern hyper\u2010inflammation in severe COVID\u201019","volume":"35","author":"Deguchi","year":"2021","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.biopha.2021.112346_bib56","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1164\/rccm.201312-2293OC","article-title":"T-regulatory cells and programmed death 1+ T cells contribute to effector T-cell dysfunction in patients with chronic obstructive pulmonary disease","volume":"190","author":"Kalathil","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"6","key":"10.1016\/j.biopha.2021.112346_bib57","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1164\/rccm.201302-0249OC","article-title":"Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent Mycobacterium tuberculosis infection suppresses T-cell function","volume":"188","author":"Du Plessis","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.biopha.2021.112346_bib58","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/mi.2012.62","article-title":"STAT1-regulated lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with relevance in resolution of bacterial pneumonia","volume":"6","author":"Poe","year":"2013","journal-title":"Mucosal Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112346_bib59","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00262-018-2277-y","article-title":"MDSCs in infectious diseases: regulation, roles, and readjustment","volume":"68","author":"Dorhoi","year":"2019","journal-title":"Cancer Immunol., Immunother.: CII"},{"key":"10.1016\/j.biopha.2021.112346_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2021.104302","article-title":"Myeloid-derived suppressor cells (MDSC): When good intentions go awry","volume":"362","author":"Sanchez-Pino","year":"2021","journal-title":"Cell. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2021.112346_bib61","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.cell.2020.08.001","article-title":"Severe COVID-19 is marked by a dysregulated myeloid cell compartment","volume":"182","author":"Schulte-Schrepping","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2021.112346_bib62","article-title":"Impaired T-cell and antibody immunity after COVID-19 infection in chronically immunosuppressed transplant recipients","author":"Ashokkumar","year":"2021","journal-title":"bioRxiv"},{"issue":"16","key":"10.1016\/j.biopha.2021.112346_bib63","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1093\/cid\/ciaa577","article-title":"An inflammatory profile correlates with decreased frequency of cytotoxic cells in coronavirus disease 2019","volume":"71","author":"Bordoni","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2021.112346_bib64","article-title":"Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progression","author":"Rendeiro","year":"2020","journal-title":"medRxiv"},{"issue":"2","key":"10.1016\/j.biopha.2021.112346_bib65","doi-asserted-by":"crossref","first-page":"AB39","DOI":"10.1016\/j.jaci.2020.12.173","article-title":"Blood dendritic cells, monocytes and myeloid-derived suppressor cells in patients with COVID-19 associated pneumonia","volume":"147","author":"Hancharou","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112346_bib66","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13054-020-02893-8","article-title":"SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression","volume":"24","author":"Yu","year":"2020","journal-title":"Crit. Care"},{"issue":"4","key":"10.1016\/j.biopha.2021.112346_bib67","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/intimm\/dxab005","article-title":"Myeloid cell dynamics correlating with clinical outcomes of severe COVID-19 in Japan","volume":"33","author":"Takano","year":"2021","journal-title":"Int. Immunol."},{"key":"10.1016\/j.biopha.2021.112346_bib68","article-title":"Emergence of immunosuppressive LOX-1+ PMN-MDSC in septic shock and severe COVID-19 patients with acute respiratory distress syndrome","author":"Coudereau","year":"2021","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112346_bib69","first-page":"318","article-title":"Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19","volume":"81","author":"Liu","year":"2020","journal-title":"J. Infect."},{"issue":"1","key":"10.1016\/j.biopha.2021.112346_bib70","doi-asserted-by":"crossref","first-page":"66","DOI":"10.14348\/molcells.2014.2282","article-title":"Myeloid-derived suppressor cells are associated with viral persistence and downregulation of TCR \u03b6 chain expression on CD8+ T cells in chronic hepatitis C patients","volume":"37","author":"Zeng","year":"2014","journal-title":"Mol. Cells"},{"issue":"4","key":"10.1016\/j.biopha.2021.112346_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc14003","article-title":"Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients","volume":"18","author":"Darcy","year":"2014","journal-title":"Crit. Care"},{"issue":"6","key":"10.1016\/j.biopha.2021.112346_bib72","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144734","article-title":"Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity","volume":"131","author":"Falck-Jones","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2021.112346_bib73","article-title":"Induction of a regulatory myeloid program in bacterial sepsis and severe COVID-19","author":"Reyes","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2021.112346_bib74","article-title":"Transcriptome and functions of granulocytic myeloid-derived suppressor cells determine their association with disease severity of COVID-19","author":"Dean","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.biopha.2021.112346_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110168","article-title":"Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5\/14","volume":"144","author":"Murch","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"6","key":"10.1016\/j.biopha.2021.112346_bib76","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.biopha.2021.112346_bib77","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cell.2020.08.002","article-title":"Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19","volume":"182","author":"Silvin","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2021.112346_bib78","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/JLB.4COVCRA0820-481RRR","article-title":"Neutrophils mediate Th17 promotion in COVID\u201019 patients","volume":"109","author":"Parackova","year":"2021","journal-title":"J. Leukoc. Biol."},{"issue":"331","key":"10.1016\/j.biopha.2021.112346_bib79","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1126\/scitranslmed.aae0482","article-title":"Arginase-1\u2013dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus","volume":"8","author":"Wu","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.biopha.2021.112346_bib80","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1084\/jem.20121277","article-title":"Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling","volume":"210","author":"Obermajer","year":"2013","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.biopha.2021.112346_bib81","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1089\/vim.2016.0125","article-title":"The role of myeloid-derived suppressor cells in viral infection","volume":"30","author":"O\u2019Connor","year":"2017","journal-title":"Viral Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112346_bib82","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/med.21756","article-title":"SARS-CoV-2-mediated immune system activation and potential application in immunotherapy","volume":"41","author":"Tan","year":"2021","journal-title":"Med. Res. Rev."},{"issue":"8","key":"10.1016\/j.biopha.2021.112346_bib83","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.3390\/cells10082111","article-title":"Expansion of myeloid derived suppressor cells contributes to platelet activation by L-arginine deprivation during SARS-CoV-2 infection","volume":"10","author":"Sacchi","year":"2021","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.biopha.2021.112346_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108863","article-title":"Metabolic programs define dysfunctional immune responses in severe COVID-19 patients","volume":"34","author":"Thompson","year":"2021","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.biopha.2021.112346_bib85","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cmet.2013.06.018","article-title":"Immunoresponsive gene 1 augments bactericidal activity of macrophage-lineage cells by regulating \u03b2-oxidation-dependent mitochondrial ROS production","volume":"18","author":"Hall","year":"2013","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.biopha.2021.112346_bib86","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/nm.4153","article-title":"NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages","volume":"22","author":"Moon","year":"2016","journal-title":"Nat. Med."},{"issue":"7821","key":"10.1016\/j.biopha.2021.112346_bib87","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biopha.2021.112346_bib88","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bbabio.2008.11.009","article-title":"Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase","volume":"1787","author":"Shoshan-Barmatz","year":"2009","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Bioenerg."},{"issue":"3","key":"10.1016\/j.biopha.2021.112346_bib89","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.biopha.2021.112346_bib90","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41590-020-0666-9","article-title":"Regulatory myeloid cells paralyze T cells through cell-cell transfer of the metabolite methylglyoxal","volume":"21","author":"Baumann","year":"2020","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112346_bib91","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.it.2010.10.002","article-title":"Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function","volume":"32","author":"Condamine","year":"2011","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112346_bib92","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1183\/13993003.01572-2015","article-title":"The emerging role of myeloid-derived suppressor cells in lung diseases","volume":"47","author":"Kolahian","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"34","key":"10.1016\/j.biopha.2021.112346_bib93","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024358118","article-title":"Redox imbalance links COVID-19 and myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"118","author":"Paul","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2021.112346_bib94","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.intimp.2010.08.025","article-title":"L-arginine reduces mitochondrial dysfunction and airway injury in murine allergic airway inflammation","volume":"10","author":"Mabalirajan","year":"2010","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2021.112346_bib95","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.3389\/fimmu.2018.02499","article-title":"Reactive oxygen species as regulators of MDSC-mediated immune suppression","volume":"9","author":"Ohl","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2021.112346_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101734","article-title":"Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro","volume":"37","author":"Akaberi","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2021.112346_bib97","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.niox.2020.06.002","article-title":"Tackle the free radicals damage in COVID-19","volume":"102","author":"Wu","year":"2020","journal-title":"Nitric Oxide"},{"issue":"56","key":"10.1016\/j.biopha.2021.112346_bib98","doi-asserted-by":"crossref","first-page":"30814","DOI":"10.18632\/oncotarget.25720","article-title":"Cell based functional assays for IDO1 inhibitor screening and characterization","volume":"9","author":"Richards","year":"2018","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.biopha.2021.112346_bib99","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200111","article-title":"Mechanisms of immune suppression by myeloid-derived suppressor cells: The role of interleukin-10 as a key immunoregulatory cytokine","volume":"10","author":"Yaseen","year":"2020","journal-title":"Open Biol."},{"key":"10.1016\/j.biopha.2021.112346_bib100","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.4049\/jimmunol.2100228","article-title":"Suppressive monocytes impair MAIT cells response via IL-10 in patients with severe COVID-19","volume":"207","author":"Yang","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2021.112346_bib101","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3389\/fimmu.2020.01680","article-title":"The new era of cancer immunotherapy: targeting myeloid-derived suppressor cells to overcome immune evasion","volume":"11","author":"De Cicco","year":"2020","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2021.112346_bib102","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s40520-020-01677-y","article-title":"Evidence for possible association of vitamin D status with cytokine storm and unregulated inflammation in COVID-19 patients","volume":"32","author":"Daneshkhah","year":"2020","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.biopha.2021.112346_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105557","article-title":"1\u03b1, 25 Dihydroxyvitamin D (1,25(OH)(2)D) inhibits the T cell suppressive function of myeloid derived suppressor cells (MDSC)","volume":"198","author":"Fleet","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.biopha.2021.112346_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104259","article-title":"Effects of vitamin D on macrophages and myeloid-derived suppressor cells (MDSCs) hyperinflammatory response in the lungs of COVID-19 patients","volume":"360","author":"Kloc","year":"2021","journal-title":"Cell. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2021.112346_bib105","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: a single center experience","volume":"92","author":"Luo","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.biopha.2021.112346_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104361","article-title":"The clinical course and its correlated immune status in COVID-19 pneumonia","volume":"127","author":"He","year":"2020","journal-title":"J. Clin. Virol."},{"issue":"24","key":"10.1016\/j.biopha.2021.112346_bib107","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1056\/NEJMoa2028836","article-title":"Efficacy of tocilizumab in patients hospitalized with Covid-19","volume":"383","author":"Stone","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2021.112346_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110122","article-title":"Prostaglandin D(2) as a mediator of lymphopenia and a therapeutic target in COVID-19 disease","volume":"143","author":"Gupta","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"3","key":"10.1016\/j.biopha.2021.112346_bib109","article-title":"Ramatroban as a novel immunotherapy for COVID-19","volume":"14","author":"Gupta","year":"2020","journal-title":"J. Mol. Genet. Med.: Int. J. Biomed. Res."},{"issue":"2","key":"10.1016\/j.biopha.2021.112346_bib110","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.chom.2020.12.016","article-title":"Induction of alarmin S100A8\/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19","volume":"29","author":"Guo","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"7450","key":"10.1016\/j.biopha.2021.112346_bib111","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature12118","article-title":"The TLR4 antagonist Eritoran protects mice from lethal influenza infection","volume":"497","author":"Shirey","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2021.112346_bib112","article-title":"Disruption of the CCL5\/RANTES-CCR5 pathway restores immune homeostasis and reduces plasma viral load in critical COVID-19","author":"Patterson","year":"2020","journal-title":"MedRxiv"},{"issue":"1","key":"10.1016\/j.biopha.2021.112346_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-03400-9","article-title":"Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes","volume":"24","author":"van Paassen","year":"2020","journal-title":"Crit. Care"},{"issue":"7","key":"10.1016\/j.biopha.2021.112346_bib114","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/cid\/ciaa829","article-title":"High-dose but not low-dose corticosteroids potentially delay viral shedding of patients with COVID-19","volume":"72","author":"Li","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2021.112346_bib115","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001019","article-title":"Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management","volume":"8","author":"Mart\u00e9","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"23","key":"10.1016\/j.biopha.2021.112346_bib116","doi-asserted-by":"crossref","first-page":"13703","DOI":"10.1111\/jcmm.15928","article-title":"Methylprednisolone alleviates multiple sclerosis by expanding myeloid\u2010derived suppressor cells via glucocorticoid receptor \u03b2 and S100A8\/9 up\u2010regulation","volume":"24","author":"Wang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2021.112346_bib117","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3389\/fmed.2020.580677","article-title":"Frequencies of CD33+ CD11b+ HLA-DR\u2013CD14\u2013CD66b+ and CD33+ CD11b+ HLA-DR\u2013CD14+ CD66b\u2013cells in peripheral blood as severity immune biomarkers in COVID-19","volume":"7","author":"Alberca","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.biopha.2021.112346_bib118","article-title":"Myeloid-derived suppressor cells in the blood of Iranian COVID-19 patients","author":"Mortaz","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.biopha.2021.112346_bib119","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.omtm.2020.11.002","article-title":"Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection","volume":"20","author":"Sharif-Askari","year":"2021","journal-title":"Mol. Ther. -Methods Clin. Dev."},{"issue":"10","key":"10.1016\/j.biopha.2021.112346_bib120","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/imcb.12296","article-title":"Protective effect of LDK 378 during sepsis: a novel mechanism of action targeting myeloid\u2010derived suppressor cells","volume":"97","author":"Patil","year":"2019","journal-title":"Immunol. Cell Biol."},{"issue":"8","key":"10.1016\/j.biopha.2021.112346_bib121","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nri1668","article-title":"Regulation of immune responses by L-arginine metabolism","volume":"5","author":"Bronte","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112346_bib122","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1182\/blood-2006-06-031856","article-title":"L-arginine availability regulates T-lymphocyte cell-cycle progression","volume":"109","author":"Rodriguez","year":"2007","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.biopha.2021.112346_bib123","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1038\/jid.2012.190","article-title":"Nitric oxide-producing myeloid-derived suppressor cells inhibit vascular E-selectin expression in human squamous cell carcinomas","volume":"132","author":"Gehad","year":"2012","journal-title":"J. Invest. Dermatol."},{"issue":"12","key":"10.1016\/j.biopha.2021.112346_bib124","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.4049\/jimmunol.1201018","article-title":"Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth","volume":"189","author":"Schlecker","year":"2012","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112346_bib125","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1084\/jem.20140835","article-title":"Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells","volume":"212","author":"Ortiz","year":"2015","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.biopha.2021.112346_bib126","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tips.2018.10.008","article-title":"MDSC; the most important cell you have never heard of","volume":"40","author":"Tesi","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2021.112346_bib127","doi-asserted-by":"crossref","unstructured":"E.A. Thompson, K. Cascino, A.A. Ordonez, W. Zhou, A. Vaghasia, A. Hamacher-Brady, N.R. Brady, I.-H. Sun, R. Wang, A.Z. Rosenberg, M. Delannoy, R. Rothman, K. Fenstermacher, L. Sauer, K. Shaw-Saliba, E.M. Bloch, A.D. Redd, A.A. Tobian, M. Horton, K. Smith, A. Pekosz, F.R. D'Alessio, S. Yegnasubramanian, H. Ji, A.L. Cox, J.D. Powell, Mitochondrial induced T cell apoptosis and aberrant myeloid metabolic programs define distinct immune cell subsets during acute and recovered SARS-CoV-2 infection, medRxiv: the preprint server for health sciences, 2020: 2020.09.10.20186064.","DOI":"10.1101\/2020.09.10.20186064"},{"issue":"7","key":"10.1016\/j.biopha.2021.112346_bib128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009721","article-title":"Characterization of low-density granulocytes in COVID-19","volume":"17","author":"Cabrera","year":"2021","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.biopha.2021.112346_bib129","first-page":"872","article-title":"Immunosuppressive CD14+ HLA-DRlow\/\u2212 monocytes in B-cell non-Hodgkin lymphoma, Blood","volume":"117","author":"Lin","year":"2011","journal-title":"J. Am. Soc. Hematol."},{"issue":"6","key":"10.1016\/j.biopha.2021.112346_bib130","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.7150\/jca.29647","article-title":"Increased circulating GrMyeloid-derived suppressor cells correlated with tumor burden and survival in locally advanced cervical cancer patient","volume":"10","author":"Liang","year":"2019","journal-title":"J. Cancer"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221011306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221011306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:42:10Z","timestamp":1760100130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221011306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":130,"alternative-id":["S0753332221011306"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112346","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of myeloid-derived suppressor cells in viral respiratory infections; Hints for discovering therapeutic targets for COVID-19","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112346","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112346"}}